Article Details
Retrieved on: 2025-01-20 21:07:14
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
... diabetes. This new patent protects the use of Imeglimin for type-2 diabetic patients with moderate to severe renal impairment until 2039. The ...
Article found on: www.biospace.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here